Genelux Corporation
GNLX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $143 | $0 | $0 |
| Gross Profit | $0 | -$143 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $4,741 | $4,758 | $4,698 | $6,520 |
| G&A Expenses | $3,453 | $3,034 | $3,118 | $3,228 |
| SG&A Expenses | $3,453 | $3,034 | $3,118 | $3,228 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$143 | $0 | $0 |
| Operating Expenses | $8,194 | $7,649 | $7,816 | $9,748 |
| Operating Income | -$8,194 | -$7,792 | -$7,816 | -$9,748 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $244 | $336 | $324 | $772 |
| Pre-Tax Income | -$7,950 | -$7,456 | -$7,492 | -$8,976 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$7,950 | -$7,456 | -$7,492 | -$8,976 |
| % Margin | – | – | – | – |
| EPS | -0.21 | -0.2 | -0.21 | -0.27 |
| % Growth | -5% | 4.8% | 22.2% | – |
| EPS Diluted | -0.21 | -0.2 | -0.21 | -0.27 |
| Weighted Avg Shares Out | 37,893 | 37,946 | 34,926 | 31,451 |
| Weighted Avg Shares Out Dil | 37,893 | 37,946 | 34,926 | 31,451 |
| Supplemental Information | – | – | – | – |
| Interest Income | $244 | $336 | $324 | $402 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $144 | $143 | $139 | $227 |
| EBITDA | -$7,806 | -$7,313 | -$7,677 | -$8,749 |
| % Margin | – | – | – | – |